Reviews
Reviewer: Carcinoid Cancer Foundation, USA
Review: "The first mobile app for carcinoid cancer and neuroendocrine tumor (NET) patients is available for downloading on the iPhone, iPad, and Android. ‘My NET Manager’, a free app by Novartis Oncology, offers patients a unique opportunity to track their symptoms, set reminders, access test results, and view important dates. The app includes a medication tracker, an insurance tracker, a place to list physicians’ names and contact information, information about NETs, including a glossary, and more. ... A ‘Contacts’ section offers the app user a place to list laboratories, doctors, pharmacies, and insurance companies.”
Source: http://bit.ly/1ndsoJzUsage: Not specified
Weblink of reviewer: http://bit.ly/1gTTw0N
Reviewer: Caring for Carcinoid Foundation (CFCF), USA
Review: “The Net Alliance, a patient education and support initiative of Novartis Oncology, announces their new mobile app for patients with neuroendocrine tumors (NETs). This mobile app will help individuals track symptoms, set reminders, view important dates, share information and manually input test results if a provider does not have electronic medical records. Patients now have the ability to organise their care with an all-inclusive app.”
Source: http://bit.ly/1ndt1mlUsage: Not specified
Weblink of reviewer: http://bit.ly/1ndt1mn
Reviewer: Northern California CarciNET Community (NorCal CarciNET Community), USA
Review: “ ‘My NET Manager’ from Novartis will help you track your symptoms, as well as manually input test results if your provider does not have electronic medical records. Manage your NET with My NET Manager, the first mobile app for patients with neuroendocrine tumors (NETs). Patients now have the ability to organise their care with an all-inclusive mobile app.”
Source: http://bit.ly/1ndtqFnUsage: Not specified
Weblink of reviewer: http://bit.ly/1ndtqFq